J. Pullman

In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.

K. Carroll, D. Stevens, A. Bryant, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cadazolid for the treatment of Clostridium difficile infection: results of two double- blind, double-dummy, non-inferiority, randomised controlled phase 3 trials

D. Gerding, C. Nord, O. Cornely, 2019 .

The effect of tetracycline fiber therapy on beta-glucuronidase and interleukin-1 beta in crevicular fluid.

I. Lamster, J. Grbic, R. Celenti, 1996, Journal of clinical periodontology.

S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Fu Lee Wang, Young Keun Kim, Á. Soriano, 2022, The Lancet.

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

S. Cammarata, J. Gardovskis, E. Sun, 2017, The Journal of antimicrobial chemotherapy.

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

F. Trautinger, M. Wilcox, L. Bush, 2010, The Journal of antimicrobial chemotherapy.

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

C. Schumann, T. File, P. Eckburg, 2011, The Journal of antimicrobial chemotherapy.

Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies

P. Altmeyer, G. Rahav, D. Zeltser, 2018, Antimicrobial Agents and Chemotherapy.